JCOIN Issue Briefs
Issue Brief: Considerations for Initiation of OUD Medications for Patients Recently Released from Controlled Environments
Download the Issue Brief (PDF) Background People with a history of opioid use disorder (OUD) who were not being treated with medication for OUD at the time of release from incarceration will have varying degrees of opioid tolerance and physical dependence. These will depend on their opioid use just prior to incarceration (for relatively short…
Read MoreIssue Brief: Medications for Opioid and Alcohol Use Disorders: Research Insights for Criminal Justice Professionals
Key Takeaways Medications for Substance Use Disorders Are Effective Treatments. Methadone, buprenorphine, and naltrexone are FDA-approved medications for the treatment of opioid use disorder (OUD). Naltrexone, acamprosate, and disulfiram are FDA-approved medications for the treatment of alcohol use disorder (AUD). These medications are effective in reducing substance use and improving recovery outcomes. Patient Choice Matters.…
Read MoreIssue Brief: Treating Opioid Use Disorder in Justice-Involved Populations
Download the Issue Brief (PDF) Opioid use disorder (OUD) is a medical condition that is treatable. Individuals involved in the criminal justice system should be screened for OUD. Anyone with moderate to severe OUD should have access to medication treatment for OUD in all criminal justice settings and upon release. OUD is a treatable illness,…
Read More